Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma, Large B-Cell, Diffuse × Base Sequence × Clear all

Status

Unknown 1 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Leukemia 2 Toxoplasmosis 1 Thrombocytosis 1 Myeloproliferative Disorders 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Congenital Abnormalities 1 Carcinoma, Renal Cell 1 Adenocarcinoma of Lung 1

Interventions

Rituximab 49 Cyclophosphamide 35 Vincristine 23 Prednisone 22 Doxorubicin 20 Etoposide 17 Cytarabine 17 Lenalidomide 16 Gemcitabine 12 Melphalan 8 Filgrastim 8 Cisplatin 8 Peripheral Blood Stem Cell Transplantation 7 Oxaliplatin 7 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Ifosfamide 7 Carmustine 7 Methotrexate 6 zanubrutinib 5 Vindesine 5 Radiotherapy 5 R-CHOP protocol 5 Dexamethasone 5 Busulfan 5 ibrutinib 4 fludarabine phosphate 4 Methylprednisolone 4 Decitabine 4 Cyclosporine 4 Bendamustine Hydrochloride 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04183569 2020-04-29

PROTEOM

University Hospital, Bordeaux

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡